They also demonstrated that the depletion of circAGFG1 decreased PKM2 expression to suppress glycolysis, oxaliplatin resistance and cellular growth in CRC through competitive binding with miR‐7‐5p [107]. The gene discussed is PKM; the disease is colorectal carcinoma.